Induced Hypothermia in Cardiac Arrest Patients Rescued by Extracorporeal Cardiopulmonary Resuscitation.

NCT ID: NCT00965016

Last Updated: 2009-08-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

EARLY_PHASE1

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Cardiopulmonary resuscitation (CPR) with closed-chest cardiac massage has been shown that survival to discharge rate is poor. Attempt to increase success, some aggressive methods such as extracorporeal membrane oxygenation (ECMO) has been used (also known as extracorporeal cardiopulmonary resuscitation, ECPR). Otherwise, anoxic brain injury is another issue after CPR. In recent years, some randomized prospective controlled trials of induced hypothermia (IH) to 33℃ for 12 to 24 hours has been demonstrated to significantly improve outcome in cardiac arrest patients. Because ECMO also could provide hypothermia management, we plan this study to evaluate the cerebroprotective effect of ECPR with induced hypothermia. We will try to analyze risk factors influencing patient survival and weaning from ECPR and the optimal management for this ominous prognosis group.

Method:

The patients were recruited into the ECPR group only if they:

1. in cardiac arrest that necessitated external or open-chest cardiac massage and a large amount of epinephrine (\>5 mg) during CPR.
2. Could not be returned to spontaneous circulation within 10 to 20 min. After ECPR, the body temperature was started to be cooled down. Within 3 hours, the patients have been well studied to search for potential reason of CPR. If the patients have no heart problem or only intervention needed, they can be grouped into 1. Group 2 is the group, which some further operation must be delivered. Group 3 is the group who cannot afford to receive hypothermia (The physician in charge don't agree the trial.) In ECMO-supported patients, two resulting comparisons were of concern: 1) ECMO weaning versus nonweaning and 2) survival-to-discharge versus in-hospital death. We attempted to identify the risk factors that affected weaning and survival, and we analyzed the effect of ECPR with hypothermia on survival.

Expected result:

We will prove ECPR with hypothermia is a perfect strategy. And within three groups of the patients, ECMO +induced hypothermia will be the most optimal choice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Induced Hypothermia Protocol for comatose patient from CPR Core temperature: 34.9℃ within 30 min, 33.5℃ within 120min and 33℃ for 12-24 Hours

* Decrease temperature in 0.9℃/hour
* CVP monitoring
* the infusions were temporarily stopped if CVP increased \> 5 mm Hg over 5 mins.
* Continuous temperature monitoring with a rectal probe or bladder catheter
* One must be vigilant to avoid k+, Ma2+, and P depletion during and immediately after the infusion, particularly given the increased risk of cardiac arrhythmia that occurs with induced hypothermia.
* An evaluation of neurologic status
* IV Dormicum (midazolam 2 to 5 mg或0.125 mg/kg/hr initially) and fentanyl (0.002 mg/kg/hr initially), Pavulon (pancuronium 0.1 mg/kg) every 2 hours for a total of 32 hours.
* ABG values were used to adjust the ventilator to maintain PaO2\>100 mm Hg and PaCO2\<40 mm Hg.
* MAP: 90 \~ 100 mm Hg
* Lidocaine bolus (1 mg/kg) followed by an infusion (2 mg/min for 24 hours)
* K+\> 4.0 mmol/L
* RI infusion \< 180 mg/deciliter (10 mmol per liter)
* Antibiotics with β-lactam;Aspirin
* The temperature was maintained at 33℃ for 24 hours from the start of cooling, followed by passive rewarming, which we expected would occur over a period of 8 hours, followed by active rewarming.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Out-of-Hospital Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No Hypothermia, No intervention, ECMO

No hypothermia used during ECPR

Group Type SHAM_COMPARATOR

hypothermia

Intervention Type PROCEDURE

Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour

Hypothermia, intervention, ECMO

Hypothermia + intervention

Group Type ACTIVE_COMPARATOR

hypothermia

Intervention Type PROCEDURE

Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour

Hypothermia, no intervention, ECMO

Hypothermia without intervention after ECMO

Group Type ACTIVE_COMPARATOR

hypothermia

Intervention Type PROCEDURE

Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hypothermia

Core temperature --\> 34.9℃ within 30 min --\> 33.5℃ within 120min --\> 33℃for 24 H Decrease temperature in 0.9℃/hour

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ECPR

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. in cardiac arrest that necessitated external or open-chest cardiac massage and a large amount of epinephrine (\>5 mg) during CPR.
* 2\. Could not be returned to spontaneous circulation within 10 to 20 min

Exclusion Criteria

* contraindicated to ECMO use
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Min-Sheng General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Min-Sheng General Hospital

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shaojung Li, physician

Role: PRINCIPAL_INVESTIGATOR

Director, department of cardiovascular surgery

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Min-sheng General Hospital

Taoyuan District, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shaojung Li, physician

Role: CONTACT

886-3-3179599 ext. 8528

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yao, Physician

Role: primary

886-3-3179599 ext. 2007

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSEIRB0980106

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy and Safety of TTM in Adults With ECPR.
NCT06608095 ACTIVE_NOT_RECRUITING NA
Evaluation of MTH in PCI Under VA-ECMO for AMICS
NCT07186972 NOT_YET_RECRUITING NA